185 related articles for article (PubMed ID: 17875108)
1. Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S; Salama A; Sánchez Y; Azuara ML; Barcia E
J Clin Pharm Ther; 2007 Oct; 32(5):441-4. PubMed ID: 17875108
[TBL] [Abstract][Full Text] [Related]
2. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD; Schneider JJ; Ravenscroft PJ
J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
[TBL] [Abstract][Full Text] [Related]
3. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
Negro S; Reyes R; Azuara ML; Sánchez Y; Barcia E
Int J Pharm; 2006 Jan; 307(2):278-84. PubMed ID: 16297583
[TBL] [Abstract][Full Text] [Related]
4. Compatibiliity and stability of furosemide and dexamethasone combined in infusion solutions.
Negro S; Rendon AL; Azuara ML; Sánchez Y; Fernández-Carballido A; Barcia E
Arzneimittelforschung; 2006; 56(10):714-20. PubMed ID: 17225568
[TBL] [Abstract][Full Text] [Related]
5. Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.
Barcia E; Martín A; Azuara ML; Sánchez Y; Negro S
Support Care Cancer; 2007 Jan; 15(1):57-62. PubMed ID: 16847606
[TBL] [Abstract][Full Text] [Related]
6. Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5+/-3 degrees C.
Lebitasy M; Hecq JD; Vanbeckbergen D; Jamart J; Galanti L
Ann Pharm Fr; 2009 Jul; 67(4):272-7. PubMed ID: 19596101
[TBL] [Abstract][Full Text] [Related]
7. Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.
Negro S; Martín A; Azuara ML; Sánchez Y; Barcia E
J Pain Symptom Manage; 2005 Aug; 30(2):192-9. PubMed ID: 16125035
[TBL] [Abstract][Full Text] [Related]
8. Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Lin TF; Lin FS; Chou WH; Yeh YC; Lin CP; Fan SZ; Sun WZ
Acta Anaesthesiol Taiwan; 2010 Sep; 48(3):117-21. PubMed ID: 20864059
[TBL] [Abstract][Full Text] [Related]
9. Long-term stability of the hydrochlorides of tramadol and alizapride in dextrose 5% polyolefin bag at 5+/-3 degrees C.
Athanasopoulos A; Hecq JD; Vanbeckbergen D; Jamart J; Galanti L
Ann Pharm Fr; 2010 May; 68(3):157-62. PubMed ID: 20569772
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery.
Gu J; Qin W; Chen F; Xia Z
Med Sci Monit; 2015 Aug; 21():2528-34. PubMed ID: 26306476
[TBL] [Abstract][Full Text] [Related]
11. Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine N-butyl bromide: retrospective clinical evaluation.
Negro S; Martín A; Azuara L; Sánchez Y; Barcia E
J Palliat Med; 2010 Mar; 13(3):273-7. PubMed ID: 20078209
[TBL] [Abstract][Full Text] [Related]
12. Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4 degrees C.
Athanasopoulos A; Hecq JD; Vanbeckbergen D; Jamart J; Galanti L
J Oncol Pharm Pract; 2009 Dec; 15(4):195-200. PubMed ID: 19759051
[TBL] [Abstract][Full Text] [Related]
13. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR; Narducci WA; Fox JL
Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
[TBL] [Abstract][Full Text] [Related]
14. Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Barcia E; Reyes R; Luz Azuara M; Sánchez Y; Negro S
Support Care Cancer; 2003 Feb; 11(2):107-13. PubMed ID: 12560939
[TBL] [Abstract][Full Text] [Related]
15. Physico-chemical stability of butorphanol-tramadol and butorphanol-fentanyl patient-controlled analgesia infusion solutions over 168 hours.
Chen F; Fang B; Li P; Zhu X; Zhou B
Pharmazie; 2014 Aug; 69(8):585-8. PubMed ID: 25158568
[TBL] [Abstract][Full Text] [Related]
16. Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
Watson DG; Lin M; Morton A; Cable CG; McArthur DA
J Pain Symptom Manage; 2005 Jul; 30(1):80-6. PubMed ID: 16043011
[TBL] [Abstract][Full Text] [Related]
17. Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
Walker SE; DeAngelis C; Iazzetta J; Eppel JG
Am J Hosp Pharm; 1991 Oct; 48(10):2161-6. PubMed ID: 1723578
[TBL] [Abstract][Full Text] [Related]
18. Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care.
Negro S; Azuara ML; Sánchez Y; Reyes R; Barcia E
Support Care Cancer; 2002 Jan; 10(1):65-70. PubMed ID: 11777190
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.
He S; Zhu J; Xie F
Pharmazie; 2010 Jul; 65(7):467-70. PubMed ID: 20662312
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability of an infusion containing paracetamol, alizapride, ketorolac and tramadol in glass bottles at 5±3°C.
Colsoul ML; Hecq JD; Soumoy L; Charles O; Goderniaux N; Bihin B; Jamart J; Galanti L
Eur J Hosp Pharm; 2020 Mar; 27(e1):e74-e78. PubMed ID: 32296510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
